390 related articles for article (PubMed ID: 16354469)
21. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
Sofian M; Velayati AA; Aghakhani A; McFarland W; Farazi AA; Banifazl M; Eslamifar A; Ramezani A
Scand J Infect Dis; 2014 Aug; 46(8):573-7. PubMed ID: 24934986
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of treatment in 50 cases with spinal brucellosis in Babol, Northern Iran.
Smailnejad Gangi SM; Hasanjani Roushan MR; Janmohammadi N; Mehraeen R; Soleimani Amiri MJ; Khalilian E
J Infect Dev Ctries; 2012 Sep; 6(9):654-9. PubMed ID: 23000864
[TBL] [Abstract][Full Text] [Related]
23. Update on treatment options for spinal brucellosis.
Ulu-Kilic A; Karakas A; Erdem H; Turker T; Inal AS; Ak O; Turan H; Kazak E; Inan A; Duygu F; Demiraslan H; Kader C; Sener A; Dayan S; Deveci O; Tekin R; Saltoglu N; Aydın M; Horasan ES; Gul HC; Ceylan B; Kadanalı A; Karabay O; Karagoz G; Kayabas U; Turhan V; Engin D; Gulsun S; Elaldı N; Alabay S
Clin Microbiol Infect; 2014 Feb; 20(2):O75-82. PubMed ID: 24118178
[TBL] [Abstract][Full Text] [Related]
24. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.
Akova M; Uzun O; Akalin HE; Hayran M; Unal S; Gür D
Antimicrob Agents Chemother; 1993 Sep; 37(9):1831-4. PubMed ID: 8239591
[TBL] [Abstract][Full Text] [Related]
25. Human brucellosis in Northern Saudi Arabia.
Fallatah SM; Oduloju AJ; Al-Dusari SN; Fakunle YM
Saudi Med J; 2005 Oct; 26(10):1562-6. PubMed ID: 16228056
[TBL] [Abstract][Full Text] [Related]
26. Treatment of human brucellosis.
Solera J
J Med Liban; 2000; 48(4):255-63. PubMed ID: 11214198
[TBL] [Abstract][Full Text] [Related]
27. Brucella canis endocarditis: case report.
Ying W; Nguyen MQ; Jahre JA
Clin Infect Dis; 1999 Dec; 29(6):1593-4. PubMed ID: 10585833
[No Abstract] [Full Text] [Related]
28. Brucellosis in children of Dhofar Region, Oman.
El-Amin EO; George L; Kutty NK; Sharma PP; Choithramani RS; Jhaveri VP; Salil P; Bedair SM
Saudi Med J; 2001 Jul; 22(7):610-5. PubMed ID: 11479644
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of human brucellosis with rifampicin].
Godeau P; Fuchs G; Guillevin L; Philippon A; Tucat G; Cabane J; Herson S
Sem Hop; 1984 Jan; 60(1):5-9. PubMed ID: 6320435
[TBL] [Abstract][Full Text] [Related]
30. Antibiotics for treating human brucellosis.
Yousefi-Nooraie R; Mortaz-Hejri S; Mehrani M; Sadeghipour P
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007179. PubMed ID: 23076931
[TBL] [Abstract][Full Text] [Related]
31. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.
Cisneros JM; Viciana P; Colmenero J; Pachón J; Martinez C; Alarcón A
Antimicrob Agents Chemother; 1990 May; 34(5):881-3. PubMed ID: 2193624
[TBL] [Abstract][Full Text] [Related]
32. A multicenter therapeutic study of 1100 children with brucellosis.
Lubani MM; Dudin KI; Sharda DC; Ndhar DS; Araj GF; Hafez HA; al-Saleh QA; Helin I; Salhi MM
Pediatr Infect Dis J; 1989 Feb; 8(2):75-8. PubMed ID: 2649867
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of brucellosis with rifampicin and doxycycline].
Garcés JM; Verdaguer A; Gutiérrez-Cebollada J; Tàpies A; Drobnic L
Rev Clin Esp; 1987 Apr; 180(7):372-4. PubMed ID: 3602550
[No Abstract] [Full Text] [Related]
34. Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
Viale P; Furlanut M; Scudeller L; Pavan F; Negri C; Crapis M; Zamparini E; Zuiani C; Cristini F; Pea F
Int J Antimicrob Agents; 2009 Apr; 33(4):379-82. PubMed ID: 19097864
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
[TBL] [Abstract][Full Text] [Related]
36. Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen.
Pappas G; Seitaridis S; Akritidis N; Tsianos E
Int J Antimicrob Agents; 2004 Nov; 24(5):502-7. PubMed ID: 15519485
[TBL] [Abstract][Full Text] [Related]
37. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison.
Carter JD; Valeriano J; Vasey FB
J Rheumatol; 2004 Oct; 31(10):1973-80. PubMed ID: 15468362
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up.
Maas KS; Méndez M; Zavaleta M; Manrique J; Franco MP; Mulder M; Bonifacio N; Castañeda ML; Chacaltana J; Yagui E; Gilman RH; Guillen A; Blazes DL; Espinosa B; Hall E; Abdoel TH; Smits HL
Am J Trop Med Hyg; 2007 Apr; 76(4):698-702. PubMed ID: 17426173
[TBL] [Abstract][Full Text] [Related]
39. [The treatment of brucellosis using rifampicine (author's transl)].
Bertrand A; Roux J; Janbon F; Jourdan J; Jonquet O
Nouv Presse Med; 1979 Nov; 8(44):3635-9. PubMed ID: 534216
[TBL] [Abstract][Full Text] [Related]
40. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.
Colmenero Castillo JD; Hernandez Marquez S; Reguera Iglesias JM; Cabrera Franquelo F; Rius Diaz F; Alonso A
Chemotherapy; 1989; 35(2):146-52. PubMed ID: 2667903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
